Many somatic genetic alterations including those in BRAF, HRAS, KRAS, NRAS, PTEN, and HER1 have been revealed to play fundamental roles in the tumorigenesis of thyroid carcinoma. This evidence concerns the gene PTEN and thyroid gland carcinoma.